How can the study of ESCO2 improve therapeutic strategies?
Histological examination of tissues with altered ESCO2 expression can guide the development of targeted therapies. For instance, if a certain cancer exhibits ESCO2-related chromosomal instability, therapies aimed at stabilizing chromatid cohesion can be developed. Additionally, ESCO2 can serve as a biomarker for the early detection of diseases characterized by cohesion defects.
